UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000044639 |
|---|---|
| Receipt number | R000050973 |
| Scientific Title | Prevalence of autism spectrum disorder and attention-deficit hyperactivity disorder in adults with chronic pain in Japan |
| Date of disclosure of the study information | 2021/08/01 |
| Last modified on | 2021/06/24 13:44:59 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Prevalence of autism spectrum disorder and attention-deficit hyperactivity disorder in adults with chronic pain in Japan
Acronym
epidemiological survey of ASD and ADHD with chronic pain in Japan
Scientific Title
Prevalence of autism spectrum disorder and attention-deficit hyperactivity disorder in adults with chronic pain in Japan
Scientific Title:Acronym
epidemiological survey of ASD and ADHD with chronic pain in Japan
Region
| Japan |
Condition
Condition
autism spectrum disorder, attention-deficit hyperactivity disorder
Classification by specialty
| Psychiatry |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
investigation autism spectrum disorder and atention-deficit hyperactivity disorder in adult with chronic pain in Japan
Basic objectives2
Others
Basic objectives -Others
investigation of prevalence, location, duration and causes of chronic pan in ASD and ADHD in adult in Japan
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
prevalence of prevalence of autism spectrum disorder and attention-deficit hyperactivity disorder in adults with chronic pain
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with ASD and ADHD over 20 years old
Key exclusion criteria
dementia
patients who cannot read and write Japanese
Target sample size
250
Research contact person
Name of lead principal investigator
| 1st name | YOSUKE |
| Middle name | |
| Last name | TOMINAGA |
Organization
Showa university Karasuyama hospital
Division name
Psychiatry
Zip code
157-8577
Address
6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo
TEL
03-3300-5231
ytomi@med.showa-u.ac.jp
Public contact
Name of contact person
| 1st name | YOSUKE |
| Middle name | |
| Last name | TOMINAGA |
Organization
Showa university Karasuyama hospital
Division name
Psychiatry
Zip code
157-8577
Address
6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo
TEL
03-3300-5231
Homepage URL
ytomi@med.showa-u.ac.jp
Sponsor or person
Institute
Showa university
Institute
Department
Personal name
Funding Source
Organization
Showa university
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Institutional Review Board of ShowaUniversity Karasuyama Hospital
Address
6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo
Tel
0333005231
scri@ofc.showa-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 08 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2021 | Year | 06 | Month | 24 | Day |
Date of IRB
Anticipated trial start date
| 2021 | Year | 08 | Month | 01 | Day |
Last follow-up date
| 2022 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
epidemiological study, prevalence study
Management information
Registered date
| 2021 | Year | 06 | Month | 24 | Day |
Last modified on
| 2021 | Year | 06 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050973
